Two-week methotrexate pause helps COVID booster response without significant flares

In patients with immune-mediated inflammatory diseases, a 2-week pause of methotrexate after receiving a COVID-19 vaccine booster yielded a sustained, significantly increased antibody response, without serious flares, according to a study.
“The COVID-19 pandemic has not gone away, and with the emergence of new variants and vaccine hesitancy among clinically vulnerable patients, it is important to optimize durable protection in people who are susceptible to severe COVID-19,” Abhishek Abhishek, PhD, professor of rheumatology at the University of Nottingham, in the United Kingdom,

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart